Intertek Researches Formulation Strategies To Repurpose Biologic Drugs
CAMBRIDGE, England--(BUSINESS WIRE)--Intertek, a leading quality solutions provider to industries worldwide, is researching the potential improvements in safety, efficacy and convenience for patients that can be achieved through the redevelopment of biologic medicines so that they can be administered to patients through inhalation.
The background to the research stems from the fact that while biologic drugs are a vital class of modern medicines, the vast majority of these are administered by repeated injection.
The background to the research stems from the fact that while biologic drugs are a vital class of modern medicines, the vast majority of these are administered by repeated injection.